880292

Lupin Pharmaceuticals Inc. — FEI 3004097115

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 23, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Naples, FL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report